Literature DB >> 25223575

Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis.

Ryan Ungaro1, Charles N Bernstein2, Richard Gearry3, Anders Hviid4, Kaija-Leena Kolho5, Matthew P Kronman6, Souradet Shaw2, Herbert Van Kruiningen7, Jean-Frédéric Colombel1, Ashish Atreja1.   

Abstract

OBJECTIVES: The objective of this study was to perform a meta-analysis investigating antibiotic exposure as a risk factor for developing inflammatory bowel disease (IBD).
METHODS: A literature search using Medline, Embase, and Cochrane databases was performed to identify studies providing data on the association between antibiotic use and newly diagnosed IBD. Included studies reported Crohn's disease (CD), ulcerative colitis (UC), or a composite of both (IBD) as the primary outcome and evaluated antibiotic exposure before being diagnosed with IBD. A random-effects meta-analysis was conducted to determine overall pooled estimates and 95% confidence intervals (CIs).
RESULTS: A total of 11 observational studies (8 case-control and 3 cohort) including 7,208 patients diagnosed with IBD were analyzed. The pooled odds ratio (OR) for IBD among patients exposed to any antibiotic was 1.57 (95% CI 1.27-1.94). Antibiotic exposure was significantly associated with CD (OR 1.74, 95% CI 1.35-2.23) but was not significant for UC (OR 1.08, 95% CI 0.91-1.27). Exposure to antibiotics most markedly increased the risk of CD in children (OR 2.75, 95% CI 1.72-4.38). All antibiotics were associated with IBD, with the exception of penicillin. Exposure to metronidazole (OR 5.01, 95% CI 1.65-15.25) or fluoroquinolones (OR 1.79, 95% CI 1.03-3.12) was most strongly associated with new-onset IBD.
CONCLUSIONS: Exposure to antibiotics appears to increase the odds of being newly diagnosed with CD but not UC. This risk is most marked in children diagnosed with CD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25223575     DOI: 10.1038/ajg.2014.246

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  91 in total

Review 1.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

Review 2.  Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.

Authors:  Mei Lan Chen; Mark S Sundrud
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

3.  Rosacea, Use of Tetracycline, and Risk of Incident Inflammatory Bowel Disease in Women.

Authors:  Wen-Qing Li; Eunyoung Cho; Hamed Khalili; Shaowei Wu; Andrew T Chan; Abrar A Qureshi
Journal:  Clin Gastroenterol Hepatol       Date:  2015-09-25       Impact factor: 11.382

4.  Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

Authors:  Silvia Ghione; Hélène Sarter; Mathurin Fumery; Laura Armengol-Debeir; Guillaume Savoye; Delphine Ley; Claire Spyckerelle; Benjamin Pariente; Laurent Peyrin-Biroulet; Dominique Turck; Corinne Gower-Rousseau; J M Andre; M Antonietti; A Aouakli; A Armand; I Aroichane; F Assi; J P Aubet; E Auxenfants; F Ayafi-Ramelot; D Bankovski; B Barbry; N Bardoux; P Baron; A Baudet; B Bazin; A Bebahani; J P Becqwort; V Benet; H Benali; C Benguigui; Ben E Soussan; A Bental; I Berkelmans; J Bernet; K Bernou; C Bernou-Dron; P Bertot; N Bertiaux-Vandaële; V Bertrand; E Billoud; N Biron; B Bismuth; M Bleuet; F Blondel; V Blondin; P Bohon; E Boniface; P Bonnière; E Bonvarlet; P Bonvarlet; A Boruchowicz; R Bostvironnois; M Boualit; B Bouche; C Boudaillez; C Bourgeaux; M Bourgeois; A Bourguet; A Bourienne; J Branche; G Bray; F Brazier; P Breban; H Brihier; V Brung-Lefebvre; P Bulois; P Burgiere; J Butel; J Y Canva; V Canva-Delcambre; J P Capron; F Cardot; P Carpentier; E Cartier; J F Cassar; M Cassagnou; J F Castex; P Catala; S Cattan; S Catteau; B Caujolle; G Cayron; C Chandelier; M Chantre; J Charles; T Charneau; M Chavance-Thelu; D Chirita; A Choteau; J F Claerbout; P Y Clergue; H Coevoet; G Cohen; R Collet; J F Colombel; S Coopman; J Corvisart; A Cortot; F Couttenier; J F Crinquette; V Crombe; I Dadamessi; V Dapvril; T Davion; S Dautreme; J Debas; N Degrave; F Dehont; C Delatre; R Delcenserie; O Delette; T Delgrange; L Delhoustal; J S Delmotte; S Demmane; G Deregnaucourt; P Descombes; J P Desechalliers; P Desmet; P Desreumaux; G Desseaux; P Desurmont; A Devienne; E Devouge; M Devred; A Devroux; A Dewailly; S Dharancy; A Di Fiore; D Djeddi; R Djedir; M L Dreher-Duwat; R Dubois; C Dubuque; P Ducatillon; J Duclay; B Ducrocq; F Ducrot; P Ducrotte; A Dufilho; C Duhamel; D Dujardin; C Dumant-Forest; J L Dupas; F Dupont; Y Duranton; A Duriez; K El Achkar; M El Farisi; C Elie; M C Elie-Legrand; A Elkhaki; M Eoche; D Evrard; J P Evrard; A Fatome; B Filoche; L Finet; M Flahaut; C Flamme; D Foissey; P Fournier; M C Foutrein-Comes; P Foutrein; D Fremond; T Frere; M Fumery; P Gallet; C Gamblin; P S Ganga-Zandzou; R Gérard; G Geslin; Y Gheyssens; N Ghossini; S Ghrib; T Gilbert; B Gillet; D Godard; P Godard; J M Godchaux; R Godchaux; G Goegebeur; O Goria; F Gottrand; P Gower; B Grandmaison; M Groux; C Guedon; J F Guillard; L Guillem; F Guillemot; D Guimber; B Haddouche; S Hakim; D Hanon; V Hautefeuille; P Heckestweiller; G Hecquet; J P Hedde; H Hellal; P E Henneresse; B Heyman; M Heraud; S Herve; P Hochain; L Houssin-Bailly; P Houcke; B Huguenin; S Iobagiu; A Ivanovic; I Iwanicki-Caron; E Janicki; M Jarry; J Jeu; J P Joly; C Jonas; F Katherin; A Kerleveo; A Khachfe; A Kiriakos; J Kiriakos; O Klein; M Kohut; R Kornhauser; D Koutsomanis; J E Laberenne; G Laffineur; M Lagarde; P Lannoy; J Lapchin; M Lapprand; D Laude; R Leblanc; P Lecieux; N Leclerc; C Le Couteulx; J Ledent; J Lefebvre; P Lefiliatre; C Legrand; A Le Grix; P Lelong; B Leluyer; C Lenaerts; L Lepileur; A Leplat; E Lepoutre-Dujardin; H Leroi; M Y Leroy; J P Lesage; X Lesage; J Lesage; I Lescanne-Darchis; J Lescut; D Lescut; B Leurent; P Levy; M Lhermie; A Lion; B Lisambert; F Loire; S Louf; A Louvet; M Luciani; D Lucidarme; J Lugand; O Macaigne; D Maetz; D Maillard; H Mancheron; O Manolache; A B Marks-Brunel; R Marti; F Martin; G Martin; E Marzloff; P Mathurin; J Mauillon; V Maunoury; J L Maupas; B Mesnard; P Metayer; L Methari; B Meurisse; F Meurisse; L Michaud; X Mirmaran; P Modaine; A Monthe; L Morel; P E Mortier; E Moulin; O Mouterde; J Mudry; M Nachury; NʼGuyen E Khac; B Notteghem; V Ollevier; A Ostyn; A Ouraghi; D Ouvry; B Paillot; N Panien-Claudot; C Paoletti; A Papazian; B Parent; B Pariente; J C Paris; P Patrier; L Paupart; B Pauwels; M Pauwels; R Petit; M Piat; S Piotte; C Plane; B Plouvier; E Pollet; P Pommelet; D Pop; C Pordes; G Pouchain; P Prades; A Prevost; J C Prevost; B Quesnel; A M Queuniet; J F Quinton; A Rabache; P Rabelle; G Raclot; S Ratajczyk; D Rault; V Razemon; N Reix; M Revillon; C Richez; P Robinson; J Rodriguez; J Roger; J M Roux; A Rudelli; A Saber; G Savoye; P Schlosseberg; M Segrestin; D Seguy; M Serin; A Seryer; F Sevenet; N Shekh; J Silvie; V Simon; C Spyckerelle; N Talbodec; A Techy; J L Thelu; A Thevenin; H Thiebault; J Thomas; J M Thorel; G Tielman; M Tode; J Toisin; J Tonnel; J Y Touchais; Y Touze; J L Tranvouez; C Triplet; D Turck; S Uhlen; E Vaillant; C Valmage; D Vanco; H Vandamme; E Vanderbecq; Vander E Eecken; P Vandermolen; P Vandevenne; L Vandeville; A Vandewalle; C Vandewalle; P Vaneslander; J P Vanhoove; A Vanrenterghem; P Varlet; I Vasies; G Verbiese; G Vernier-Massouille; P Vermelle; C Verne; P Vezilier-Cocq; B Vigneron; M Vincendet; J Viot; Y M Voiment; A Wacrenier; L Waeghemaecker; J Y Wallez; M Wantiez; F Wartel; J Weber; J L Willocquet; N Wizla; E Wolschies; A Zalar; B Zaouri; A Zellweger; C Ziade
Journal:  Am J Gastroenterol       Date:  2017-08-15       Impact factor: 10.864

5.  Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases.

Authors:  Ashwin N Ananthakrishnan; Chengwei Luo; Vijay Yajnik; Hamed Khalili; John J Garber; Betsy W Stevens; Thomas Cleland; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

Review 6.  Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease.

Authors:  M N Quraishi; W Shaheen; Y H Oo; T H Iqbal
Journal:  Clin Exp Immunol       Date:  2019-11-27       Impact factor: 4.330

7.  Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice.

Authors:  Valentina Caputi; Ilaria Marsilio; Viviana Filpa; Silvia Cerantola; Genny Orso; Michela Bistoletti; Nicola Paccagnella; Sara De Martin; Monica Montopoli; Stefano Dall'Acqua; Francesca Crema; Iole-Maria Di Gangi; Francesca Galuppini; Isabella Lante; Sara Bogialli; Massimo Rugge; Patrizia Debetto; Cristina Giaroni; Maria Cecilia Giron
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

8.  Immunological Consequences of Intestinal Fungal Dysbiosis.

Authors:  Matthew L Wheeler; Jose J Limon; Agnieszka S Bar; Christian A Leal; Matthew Gargus; Jie Tang; Jordan Brown; Vincent A Funari; Hanlin L Wang; Timothy R Crother; Moshe Arditi; David M Underhill; Iliyan D Iliev
Journal:  Cell Host Microbe       Date:  2016-05-26       Impact factor: 21.023

Review 9.  Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.

Authors:  Mariabeatrice Principi; Nicoletta Cassano; Antonella Contaldo; Andrea Iannone; Giuseppe Losurdo; Michele Barone; Mario Mastrolonardo; Gino Antonio Vena; Enzo Ierardi; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

Review 10.  Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Owais Bhatti; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.